DelMar Pharma
Robert E Hoffman is an accomplished executive in the biotechnology sector, currently serving as President and Chief Executive Officer of Kintara Therapeutics, Inc. (NASDAQ: KTRA) and Chairman of the Board for the same organization. In addition to these roles, Hoffman holds board memberships at ASLAN Pharmaceuticals, FibroGenesis, and Antibe Therapeutics Inc. Education includes a degree from St. Bonaventure University, completed between 1984 and 1988.
This person is not in any teams
This person is not in any offices
DelMar Pharma
DelMar Pharmaceuticals is developing new cancer therapies in areas where patients are failing or have become intolerable to currently available treatments.